polymeric carrier / polymer drug conjugation technology / chemical conjugation / optimized synthesis protocols / reticuloendothelial systems / polymeric carrier structure disintegration / tumour site / /
MedicalCondition
murine metastatic breast tumours / liver cancers / breast tumour / cancer / PG-G’s acute and chronic in vivo toxicity / tumour metastasis / tumour / acute and chronic toxicity / tumours / /
MedicalTreatment
drug therapy / /
Organization
PG-G administration / /
Product
PG-G injection / /
Technology
optimized synthesis protocols / 344 utilising polymer drug conjugation technology / polymer drug conjugation technology / /
Chapter 10 Final Discussion, Future Perspective and Conclusion 10.1 Final discussion To investigate the outcome of applying the polymer drug conjugation strategy to